Sam Hobson

485 total citations
10 papers, 309 citations indexed

About

Sam Hobson is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Clinical Biochemistry. According to data from OpenAlex, Sam Hobson has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Clinical Biochemistry. Recurrent topics in Sam Hobson's work include Dialysis and Renal Disease Management (5 papers), Parathyroid Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Sam Hobson is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Parathyroid Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Sam Hobson collaborates with scholars based in Sweden, United Kingdom and Germany. Sam Hobson's co-authors include Karolina Kublickiene, Peter Stenvinkel, Samsul Arefin, Paul G. Shiels, Anna Witasp, Thomas Ebert, Sven‐Christian Pawelzik, Magnus Bäck, Sarah Buchanan and Julia Steinmetz and has published in prestigious journals such as Circulation Research, International Journal of Molecular Sciences and Clinica Chimica Acta.

In The Last Decade

Sam Hobson

10 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sam Hobson Sweden	7	122	75	44	37	35	10	309
Mengru Zeng China	11	121 1.0×	124 1.7×	54 1.2×	36 1.0×	50 1.4×	21	350
Diana Moldovan Romania	11	111 0.9×	40 0.5×	40 0.9×	20 0.5×	27 0.8×	42	244
Edu Suárez Puerto Rico	8	84 0.7×	68 0.9×	40 0.9×	17 0.5×	56 1.6×	16	331
Jiewu Huang China	9	71 0.6×	122 1.6×	32 0.7×	33 0.9×	33 0.9×	13	280
Kyle H. Moore United States	9	55 0.5×	116 1.5×	42 1.0×	37 1.0×	27 0.8×	17	316
Min Tao China	10	65 0.5×	72 1.0×	29 0.7×	30 0.8×	28 0.8×	25	273
Changlong An United States	12	91 0.7×	149 2.0×	37 0.8×	69 1.9×	40 1.1×	16	401
Tae Yamamoto Japan	10	107 0.9×	42 0.6×	41 0.9×	23 0.6×	20 0.6×	17	249
Huihua Pang China	10	173 1.4×	124 1.7×	16 0.4×	37 1.0×	35 1.0×	19	355
Sujuan Xu China	13	110 0.9×	180 2.4×	34 0.8×	50 1.4×	26 0.7×	29	406

Countries citing papers authored by Sam Hobson

Since Specialization

Citations

This map shows the geographic impact of Sam Hobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Hobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Hobson more than expected).

Fields of papers citing papers by Sam Hobson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Hobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Hobson. The network helps show where Sam Hobson may publish in the future.

Co-authorship network of co-authors of Sam Hobson

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Hobson. A scholar is included among the top collaborators of Sam Hobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Hobson. Sam Hobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Arefin, Samsul, Sam Hobson, Federico Pietrocola, et al.. (2024). Early vascular aging in chronic kidney disease: focus on microvascular maintenance, senescence signature and potential therapeutics. Translational research. 275. 32–47. 7 indexed citations

Hobson, Sam, Justyna Siwy, Thomas Ebert, et al.. (2023). Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD. Proteomes. 11(3). 25–25. 2 indexed citations

Hobson, Sam, Samsul Arefin, Awahan Rahman, et al.. (2023). Indoxyl Sulphate Retention Is Associated with Microvascular Endothelial Dysfunction after Kidney Transplantation. International Journal of Molecular Sciences. 24(4). 3640–3640. 3 indexed citations

Hobson, Sam, Flore Duranton, Bernard Jover, et al.. (2023). Implications of Senescent Cell Burden and NRF2 Pathway in Uremic Calcification: A Translational Study. Cells. 12(4). 643–643. 6 indexed citations

Hobson, Sam, Abdul Rashid Qureshi, Lars Wennberg, et al.. (2023). Phenylacetylglutamine and trimethylamine N‐oxide: Two uremic players, different actions. European Journal of Clinical Investigation. 53(12). e14074–e14074. 7 indexed citations

Hobson, Sam, Samsul Arefin, Anna Witasp, et al.. (2023). Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies. Circulation Research. 132(8). 950–969. 36 indexed citations

Hobson, Sam, Henriëtte de Loor, Karolina Kublickiene, et al.. (2022). Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure—A Tri-National Cohort. Toxins. 14(6). 412–412. 9 indexed citations

Arefin, Samsul, Sarah Buchanan, Sam Hobson, et al.. (2020). Nrf2 in early vascular ageing: Calcification, senescence and therapy. Clinica Chimica Acta. 505. 108–118. 46 indexed citations

Ebert, Thomas, Sven‐Christian Pawelzik, Anna Witasp, et al.. (2020). Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins. 12(4). 227–227. 169 indexed citations

10.

Hobson, Sam, Samsul Arefin, Karolina Kublickiene, Paul G. Shiels, & Peter Stenvinkel. (2019). Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease—A Novel Target for Treatment. Toxins. 11(2). 82–82. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact